<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04895111</url>
  </required_header>
  <id_info>
    <org_study_id>4066</org_study_id>
    <nct_id>NCT04895111</nct_id>
  </id_info>
  <brief_title>Endobronchial Ultrasound Strain Elastography in Sarcoidosis</brief_title>
  <official_title>Role of Endobronchial Ultrasound Strain Elastography (EBUS-SE) in Sarcoidosis: a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Strain elastography (SE) is an imaging method used for the measurement of relative tissue&#xD;
      elasticity through qualitative (color pattern) or semi-quantitative methods (strain ratio or&#xD;
      strain histogram). Very recently, the first pilot study has provided preliminary evidence&#xD;
      that EBUS-SE elastography may help identify fibrotic lymph nodes in sarcoidosis and that&#xD;
      sampling lymph nodes characterized by low strain elastography, that is &quot;stiff&quot; nodes, is&#xD;
      associated with an increased risk of retrieving an inadequate sample (i.e. a sample which is&#xD;
      not representative of the lymph node tissue). The investigators hypothesize that an EBUS-SE&#xD;
      pattern indicative of lymph node stiffness will be associated with less granulomas and more&#xD;
      fibrosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the last decade, the possibility to sample under ultrasound guidance (endosonography) the&#xD;
      intrathoracic lymph nodes through the airways (endobronchial ultrasound guided, EBUS-TBNA) or&#xD;
      through the oesophagus (endoscopic ultrasound-guided fine needle aspiration,&#xD;
      EUS-FNA/EUS-b-FNA) has revolutionized the diagnostic approach to sarcoidosis. Individual&#xD;
      studies and meta-analyses performed in selected and unselected patient populations have shown&#xD;
      that EBUS and EUS both have overall diagnostic accuracy exceeding 80%. In addition,&#xD;
      endosonography provides useful information about lymph node density; indeed, the presence of&#xD;
      inhomogeneity in the lymph node texture on B-mode during endosonography represents the most&#xD;
      important factor favouring infection over sarcoidosis in patients with lymphadenopathy.&#xD;
&#xD;
      Although the diagnostic success rate of EBUS-TBNA in detecting granulomas in lymph nodes of&#xD;
      patients with suspected sarcoidosis is very high, the procedure is not foolproof and tends to&#xD;
      have a lower yield in stages II/III as compared to stage I disease. Clinical experience&#xD;
      suggests that at least some of the false-negative EBUS-TBNA results in sarcoidosis patients&#xD;
      may be caused by the presence of lymph nodes with extensive fibrosis. We aim to evaluate&#xD;
      whether EBUS-SE may help identify fibrotic lymph nodes in sarcoidosis and if the outcome of&#xD;
      EBUS-TBNA is different in lymph nodes for which EBUS-SE suggest high fibrotic content.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>• Diagnostic yield for the detection of granulomas on endosonography samples according to a mean value of the strain histogram &lt;40 or ≥40</measure>
    <time_frame>15 days</time_frame>
    <description>The diagnostic yield for the detection of granulomas will be measured on a per lymph node basis (number of lymph nodes in which the pathological exam of endosonography samples identifies granulomas/number of lymph nodes submitted to endosonography)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>• Adequacy of endosonography samples according to a mean value of the strain histogram &lt;40 or ≥40.</measure>
    <time_frame>15 days</time_frame>
    <description>The adequacy will be measured on a per lymph node basis (number of lymph nodes in which the pathological exam shows an adequate endosonography sample/number of lymph nodes submitted to endosonography) and is defined as the presence of a preponderance of lymphocytes at the pathological exam of the endosonography sample.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Correlation between the strain elastography pattern measured with the mean value of the strain histogram and the following variables: age, sex, sarcoidosis stage (I vs II vs III), duration of sarcoidosis-related symptoms.</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Sarcoidosis, Pulmonary</condition>
  <arm_group>
    <arm_group_label>Patients with suspected sarcoidosis</arm_group_label>
    <description>Consecutive patients with clinical and radiological (CT scan +/- PET) suspect of sarcoidosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endobronchial ultrasound strain elastography</intervention_name>
    <description>Measurement of tissue elasticity of hilar and mediastinal lymph nodes through strain elastography measured during an endonbronchial ultrasound examination</description>
    <arm_group_label>Patients with suspected sarcoidosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a clinical and radiological suspect of sarcoidosis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 years or older.&#xD;
&#xD;
          -  ASA physical status I-III.&#xD;
&#xD;
          -  Clinical/radiological (computed tomography) suspicion of sarcoidosis (Stages I to III)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability or unwillingness to consent.&#xD;
&#xD;
          -  Severe bleeding disorders&#xD;
&#xD;
          -  Contraindication for temporary interruption of the use of anticoagulant or&#xD;
             antiplatelet therapy different from aspirin.&#xD;
&#xD;
          -  Recent and/or uncontrolled cardiac disease, uncontrolled pulmonary hypertension.&#xD;
&#xD;
          -  Compromised upper airway (eg, concomitant head and neck cancer or central airway&#xD;
             stenosis for any reason).&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rocco Trisolini, MD</last_name>
    <phone>+390630154204</phone>
    <email>rocco.trisolini@policlinicogemelli.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fausto Leoncini, MD</last_name>
    <email>fausto.leoncini@policlinicogemelli.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario A. Gemelli IRCCS</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fausto Leoncini, MD</last_name>
      <phone>+390630154204</phone>
      <email>fausto.leoncini@policlinicogemelli.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 17, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2021</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sarcoidosis</keyword>
  <keyword>Endobronchial Ultrasound</keyword>
  <keyword>Elastography</keyword>
  <keyword>Endosonography</keyword>
  <keyword>Granuloma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoidosis, Pulmonary</mesh_term>
    <mesh_term>Sarcoidosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

